PCSK9 inhibitors
Intervention1 paper1 finding
- Humans1
Outcomes
1Lipoprotein
downin humans1−15%Very low certainty
1 study
Lipoprotein
downin humans1−15%Very low certainty
PCSK9 inhibitors decrease lipoprotein in humans (-15.3%).
Humans3 months
Lipoprotein(a) reduction with PCSK9-targeting pharmacotherapy: A prospective real-world registry study · Atherosclerosis · 23 Sep 2026